MedTrace Logo

Efficacy and Tolerance Evaluation of an Injective Treatment for the Area Around the Eyes

NCT03881189 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2019-03-21

No results posted yet for this study

Summary

Efficacy and tolerance evaluation of an intradermal injective HA and aminoacids based treatment for the area around the eyes

Conditions

  • Under-eyes Dark Circles

Interventions

DEVICE

SUNEKOS® 200

The intradermal injection procedure was performed bilaterally, on the area around the eyes including the eyelids, using periosteal and subepidermal injection techniques. This injective procedure consists of micro-wheals of 0.2 ml just above the periosteum and micro-wheals of 0.1 ml very superficially, just under epidermis.

Sponsors & Collaborators

  • Derming SRL

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
30 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-11-28
Primary Completion
2019-03-12
Completion
2019-03-12

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03881189 on ClinicalTrials.gov